In the context of the data presented in this contribution, high blood glucose levels may suppress GPER1 expression thus minimizing the regulation of IGF-1-dependent signaling in breast cancer cells by disrupting the relative levels of expression for the multiple ERs compared to the relative levels observed when circulating glucose levels are normal. The gene discussed is GPER1; the disease is breast carcinoma.